Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Patient Information Leaflet last updated on the eMC: 17/06/2011
PIL Combivent UDVs

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 14/07/2010 and displayed until 17/06/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change of manufacturer
Updated on 05/03/2009 and displayed until 14/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 17/09/2008 and displayed until 05/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 19/11/2007 and displayed until 17/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 29/11/2000 and displayed until 19/11/2007
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ipratropium bromide
   salbutamol sulphate